NFKB1 and urinary bladder cancer: Interestingly, genistein also sensitizes bladder cancer cells to hydroxycamptothecin treatment in vitro and in vivo through ATM/NF-κB/inhibitor of NF-κB kinase (IKK)-mediated apoptosis (35).